CliffBio
small molecule

CETRAXAL

CIPROFLOXACIN HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyLABORATORIOS SALVAT SA

Drug detail

Brand nameCETRAXAL
Active ingredientCIPROFLOXACIN HYDROCHLORIDE
StrengthEQ 0.2% BASE
Dosage formSOLUTION/DROPS
RouteOTIC
ModalitySmall molecule
FDA approvalMay 2009
Marketing statusRX

More from LABORATORIOS SALVAT SA

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

CETRAXAL patent cliff — loss of exclusivity — | CliffBio